4/A: Hims & Hers CFO Amends Insider Trading Report for Stock Option Exercises

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, filed an amended Form 4 to correct the number of stock options exercised under a pre-arranged 10b5-1 trading plan.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), filed an amended Form 4 (Form 4/A) to update previously reported stock option exercises.
• The amendment corrects the number of options exercised on May 15, 2025, as stated in the original filing.
• The reported transactions were conducted under a Rule 10b5-1 trading plan adopted by Mr. Okupe on May 31, 2024, which allows for pre-scheduled, non-discretionary trades.
• One exercise involved 548 stock options with an exercise price of $11.53, resulting in the acquisition of 548 shares of Class A Common Stock.
• Another exercise involved 5,889 stock options with an exercise price of $5.01, leading to the acquisition of 5,889 shares of Class A Common Stock.
• Following these transactions, Mr. Okupe beneficially owns 63,784 stock options from the first type (with an original exercise price of $11.53) and 393,407 stock options from the second type (with an original exercise price of $5.01).
• The options have various vesting schedules, including one batch vesting 1/48th monthly over a 4-year period beginning April 1, 2023, and another batch with 25% vesting on the twelve-month anniversary of January 24, 2022, with the balance vesting in 36 successive equal monthly installments thereafter.

Sentiment

Score: 5

Explanation: The document is a neutral, factual report of an insider's stock option exercises and an amendment to correct a previous filing. It contains no positive or negative operational or financial news for the company, nor does it suggest any significant change in management's outlook beyond routine compensation management.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates adherence to insider trading regulations and indicates pre-scheduled, non-discretionary trades.
• The exercise of stock options by a Chief Financial Officer can be interpreted as a sign of confidence in the company's long-term prospects, as it allows the executive to acquire shares at a predetermined price.

Negatives

• No explicit negative information is contained within this routine insider transaction report.

Risks

• No specific risks related to the company's operations, financial health, or strategic outlook are disclosed in this Form 4/A filing, as its primary purpose is to report insider transactions.

Future Outlook

This Form 4/A filing does not contain forward-looking statements or guidance regarding the company's future performance, financial projections, or strategic outlook, as its primary purpose is to report insider transactions and beneficial ownership changes.

Management Comments

• "The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person."
• "The number has been updated to reflect the correct number of options exercised."

Industry Context

This filing is a routine insider transaction report specific to Hims & Hers Health, Inc.'s Chief Financial Officer and does not provide broader industry context or trends. It reflects individual compensation and trading activity rather than market-wide developments in the telehealth or consumer health sectors.

Comparison to Industry Standards

• This document reports standard insider trading activity under a Rule 10b5-1 plan, which is a common practice among executives in publicly traded companies across various industries to manage their equity compensation in compliance with SEC regulations.
• The amendment to correct a previously reported number is also a standard administrative procedure for SEC filings, ensuring accuracy in public disclosures.
• There are no specific comparable companies, projects, or results mentioned within this filing to assess against industry benchmarks regarding operational or financial performance.

Stakeholder Impact

• Shareholders: Provides transparency regarding executive stock option exercises and beneficial ownership, which is standard regulatory disclosure and helps inform investment decisions.
• Employees: No direct impact mentioned, but the exercise of options relates to executive compensation structures within the company.

Next Steps

• The company will continue to report insider transactions as required by Section 16(a) of the Securities Exchange Act of 1934.

Key Dates

Keywords

Hims & Hers Health, HIMS, SEC Form 4/A, Insider Trading, Stock Options, Oluyemi Okupe, Chief Financial Officer, 10b5-1 Plan, Beneficial Ownership